Formulation

Each coated tablet contains:
Dienogest, Ph. Eu	2 mg

Dienogest

Riliz™

Prescription Drug

Indication

Treatment of endometriosis

Dosage and mode of administration

General Dosing Recommendations:

Dienogest tablets are intended for continuous administration in women for the treatment of endometriosis.
There are reported longterm studies of dienogest use for more than 15 months.
Drug administration can be started on any day of the menstrual cycle.
May be taken with or without food

For more information on safety, precaution and other information about this product, please see the Product Insert.

Download Product Insert

Please consult your physician and other healthcare providers before taking any prescription medicines found on this site. The contents found on this page are for information purposes only. It should not be construed as a substitute for professional medical advise and should not be relied upon in that regard. You undertake to carefully read all product packaging and labels prior to use.

Caution: Food, Drugs, Devices and Cosmetics Act prohibits dispensing without prescription.